Status:
COMPLETED
Skin Manifestations Associated With Adhesives in Diabetes Technology Tools
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
The use of technological tools in the treatment of diabetes has intensified and become common in recent years. Many of these systems adhere to the skin with an adhesive in place between 2 and 14 days....
Detailed Description
The use of technological tools in the treatment of diabetes has intensified and become common in recent years. Many of these systems adhere to the skin with an adhesive in place for between 2 and 14 d...
Eligibility Criteria
Inclusion
- Men and Women
- Adult (≥ 18 years old)
- All types diabetes (1, 2, other)
- Any patient who wears or has worn an adhesive system for the treatment of diabetes (insulin pump, and/or continuous glucose monitoring system) within the last 10 years.
- Seen consecutively in consultation
- Patient who was informed on the research and are not opposed to participation.
Exclusion
- Illiteracy
- Refusal to participate in the study (refusals will be counted)
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
May 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 17 2021
Estimated Enrollment :
851 Patients enrolled
Trial Details
Trial ID
NCT04853810
Start Date
May 17 2021
End Date
November 17 2021
Last Update
January 3 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP, Lariboisière Hospital, Department of Diabetes and Endocrinology
Paris, France, 75010
2
AP-HP, Pitié-Salpêtrière Hospital, Diabetes and Metabolic Diseases Department
Paris, France, 75013
3
AP-HP, Cochin Hospital, Department of Diabetology
Paris, France, 75014
4
AP-HP, Bichat Hospital, Department of Diabetology, Endocrinology and Nutrition
Paris, France, 75877